| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.7M | +25.9% | +15.2% |
| Cost of Revenue | $6.1M | +35.5% | +16.1% |
| R&D Expense | $149K | +82.2% | -90.1% |
| SG&A Expense | $3.8M | +47.7% | -81.4% |
| Operating Income | -$3.3M | -32.4% | +85.8% |
| Interest Expense | $410K | — | — |
| Pre-tax Income | -$2.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.0M | +59.2% | -17.0% |
| Accounts Receivable | $2.6M | +2.9% | -17.9% |
| Inventory | $214K | +115.6% | +133.7% |
| Current Assets | $34.1M | +25.9% | +48.2% |
| Total Assets | $41.5M | +26.1% | +42.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.0M | -208.0% | — |
| Investing Cash Flow | -$384K | -91.0% | — |
| Financing Cash Flow | $8.5M | +493.7% | — |
| +90.2% |
| Income Tax | $11K | -86.5% | +106.0% |
| Net Income | -$2.1M | +47.4% | +90.3% |
| EPS (Basic) | -$0.03 | +40.0% | +90.6% |
| EPS (Diluted) | -$0.03 | +40.0% | +90.6% |
| $61.3M |
| +1.1% |
| +0.5% |
| Long-term Debt | $148K | -1.6% | -88.9% |
| Total Liabilities | $62.4M | +1.1% | -1.6% |
| Stockholders' Equity | -$28.0M | +0.2% | +17.1% |